Related to Medistem Signs On Academic Partners to Study Its Endometrial Regenerative Cell Therapy in TBI

• FDA Clears Geron to Start World’s First Trial with hESC Therapy
  
• California Institute for Regenerative Medicine Bankrolls 12 Grants with $243M
  
• URMC Gets $15M to Study Homspera as a Radiation-Induced Injury Countermeasure
  
• First Patient Receives ReNeuron’s Neural Stem Cell Therapy
  
• StemCells Snags Swissmedic OK to Start Neural Stem Cell Trial in Spinal Cord Injury
  
• Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
  
• Concert and WRAIR Establish CRADA for Deuterated Drug against TBI-Related Seizures
  
• Researchers Find Extended Culturing of Engineered iPSCs Doesn’t Increase Mutations
  
• Plasticell Spins Out Progenitor Labs for Regenerative Drug Discovery
  
• Sangart Raises $50M to Support Perfusion-Enhancing Treatment for Traumatic Hemorrhage
  
• U.S. Army Institute of Surgical Research Taps Arteriocyte for Orthopedic Trauma Cellular Therapies
  
• Acorda Licenses Phase II-Ready Brain and Spinal Cord Injury Candidate from Medtronic
  
• Banyan to Develop Biomarkers for Emory University’s Phase III Traumatic Brain Injury Study
  
• Cardio3 Establishes U.S. Subsidiary in Advance of Phase III Heart Failure Cell Therapy Trial
  
• Cellerix Secures €4.95M for Phase III Study of Allogeneic Adult Stem Cell Therapy
  
• FDA Sanctions NYBC’s Cord Blood Hematopoietic Progenitor Cells for Transplantation
  
• First Clinical Trial of Autologous Cardiac Stem Cells Shows Positive Results
  
• Geron Sidelines Stem Cell Programs and Cuts Workforce to Focus on Clinical Cancer Candidates
  
• Studies Show MSCs Can Deliver shRNAs to Inhibit Huntington Disease Protein
  
• Athersys’ MultiStem Program Gets $3.6M Boost